| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Psychiatrische Klinik, Universität München Munich, FRG
Medizinische Klinik Innenstadt, Universität München Munich, FRG
Reprint requests: Dr. G. Laakmann Psychiatrische Klinik Universität München Nussbaumstrasse 7 8000 München 2 Federal Republic of Germany
In twelve healthy male subjects 75 mg desimipramin (DMI) administered intramuscularly and 100 mg DMI given orally led to a prompt rise in serum growth hormone (GH) levels. The maximum level of serum GH was observed 60 min after the i.m. and 150 min after the oral administration of DMI. Chlorimipramin (CI) administered in the same manner and in the same dosages resulted in a significant increase in GH in only six out of twelve subjects. The maximum level was observed 60 min after the i.m. and 150 min after the oral administration of DMI. There was no change in the prolactin (PRL) levels after administration of DMI and CI.
Received January 1, 1977.
This article has been cited by other articles:
![]() |
P.J. Cowen and P.A. Sargent Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission J Psychopharmacol, January 1, 1997; 11(4): 345 - 348. [Abstract] [PDF] |
||||
![]() |
E. J. Sachar, U. Halbreich, G. M. Asnis, R. S. Nathan, F. S. Halpern, and L. Ostrow Paradoxical Cortisol Responses to Dextroamphetamine in Endogenous Depression Arch Gen Psychiatry, October 1, 1981; 38(10): 1113 - 1117. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |